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Abstract: Objectives: Following the recent H1N1 influenza pandemic we were able to describe seropositivity in a repre-
sentative sample of adults prior to the availability of a specific vaccine.  
Methods: This cross-sectional serological study is set in the Barwon Statistical Division, Australia. Blood samples were 
collected from September 2009 through to May 2010, from 1184 individuals (569 men, 615 women; median age 61.7 
years), randomly selected from electoral rolls. Serum was analysed for specific H1N1 immunity using a haemagglutina-
tion inhibition test. A self-report provided information about symptoms, demographics and healthcare. Associations be-
tween H1N1 infection, gender, households and occupation were determined using logistic regression, adjusting for age.  
Results: Of 1184 individuals, 129 (58 men, 71 women) were seropositive. Gender-adjusted age-specific prevalence was: 
8.3% 20-29 years, 13.5% 30-39, 10.4% 40-49, 6.5% 50-59, 9.7% 60-69, 10.3% 70-79, 18.8% 80+. Standardised preva-
lence was 10.3% (95%CI 9.6-11.0). No associations were detected between seropositivity and gender (OR=0.82, 95%CI 
0.57-1.19) or being a healthcare worker (OR=1.43, 95%CI 0.62-3.29). Smokers (OR=1.86, 95%CI 1.09-3.15) and those 
socioeconomically disadvantaged (OR=2.52, 95%CI 1.24-5.13) were at increased risk. Among 129 seropositive individu-
als, 31 reported symptoms that were either mild (n = 13) or moderate (time off work, doctor visit, n = 18). For age <60, 
39.6% of seropositive individuals reported symptoms, whereas the proportion was 13.2% for age 60+.  
Conclusions: Following the pandemic, the proportion of seropositive adults was low, but significant subclinical infection 
was found. Social disadvantage increased the likelihood of infection. The low symptom rate for older ages may relate to 
pre-existing immunity. 
Keywords: Epidemiology, H1N1, hospitalization, influenza A virus, pandemics, signs and symptoms, population-based study. 
INTRODUCTION 
 Following early reports of a novel strain of H1N1 Influ-
enza A in North America in March 2009 there was rapid 
widespread community transmission to all continents and the 
World Health Organisation (WHO) declared a global influ-
enza pandemic (http://www.who.int/mediacentre/news/state-
ments/2009/h1n1_pandemic_phase6_20090611/en/index.ht
ml). The influenza pandemic placed extraordinary demand 
on public health services around the world [1]. Eventually 
the clinical course and clinical features of the pandemic 
strain were found to be comparable to seasonal influenza [2]; 
however, there was an over representation of moderate to 
severe infection among pregnant women and obese patients 
[3-5]. No population-based serological surveys had been  
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undertaken to estimate the true incidence of infection in our 
community. We therefore used the opportunity to describe 
the seropositivity of pandemic H1N1 influenza in a sample 
of adults prior to the availability of a specific vaccine. We 
wanted to measure seropositivity in an adult population and 
estimate potential risk factors such as occupational and 
childcare exposure and also to describe the spectrum of 
clinical disease and the level of subclinical infection 
MATERIALS AND METHODOLOGY 
 This cross-sectional study is a sub-study of the Geelong 
Osteoporosis Study (GOS). Cohorts of men and women were 
selected at random from electoral rolls covering the Barwon 
Statistical Division in south-eastern Australia. In Australia 
voting is compulsory for all citizens 18 years of age or more. 
The electoral roll is a register of all eligible voters and pro-
vides the most comprehensive available list of adult Austra-
lian citizens. Age-stratified cohorts of 1494 women and 1540 
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men were recruited in 1994-7 (77% response) and 2001-6 
(67% response), respectively. At least 100 women and 100 
men were recruited in each five-year age group from 20 to 
69 years and 200 of each sex for both the 70-79 and 80+ year 
groups [6]. A further sample of 221 women listed as aged 
20-29 years on the 2005 electoral roll was recruited 2006-8 
(82% response) [6]. In 2009-10, subjects were invited to 
participate in this sub-study by providing a blood sample and 
completing a questionnaire. The study was approved by the 
Barwon Health Human Research Ethics Committee. All par-
ticipants provided informed, written consent. 
 From a potential pool of 2075 GOS participants (973 
men and 1102 women) who were alive, living in the region 
and able to be contacted, 1184 (569 men and 615 women) 
agreed to participate in this sub-study (57% response). Blood 
samples were collected between September 2009 and May 
2010, predating the roll out of the Pandemic vaccine in the 
region. Serum was aliquoted and stored at -80C for random 
batch analysis. Serum was analysed for specific H1N1 im-
munity using a haemagglutination inhibition test, performed 
at the Commonwealth Scientific and Industrial Research 
Organisation’s (CSIRO’s) Australian Animal Health Labora-
tory (AAHL) in Geelong. Seropositivity was defined as a 
titre > 1:40. 
 Height and weight were measured to the nearest 0.1 cm 
and 0.1 kg, respectively, and body mass index (BMI) was 
calculated in kg/m2. Subjects were categorised as obese if 
BMI was >30.0 kg/m2 [7]. 
 A self-report questionnaire was designed to seek infor-
mation concerning occupation, employment status, living 
arrangements (number and ages of other people living in 
household), pregnancy status, and lifestyle choices including 
medication use, smoking and alcohol consumption. Exposure 
to chronic respiratory disease (including chronic lung dis-
ease, asthma, chronic obstructive pulmonary disease and 
emphysema), chronic heart disease and diabetes were also 
documented by self-report. Details of influenza-like symp-
toms (fever >38C, cough and/or sore throat <72 hours dura-
tion), respiratory illness and vaccination history were also 
documented. Individuals who experienced an influenza-like 
illness during the study period responded to questions about 
diagnostic tests, treatment, hospital admissions and impact 
on normal activities. Symptom severity was classified as 
severe if the subject was hospitalised, moderate if the subject 
required time of work or visited a doctor; otherwise they 
were classified as mild. 
 Socioeconomic status (SES) was ascertained using the 
Australian Bureau of Statistic’s (ABS) Index of Relative 
Socioeconomic Advantage and Disadvantage (IRSAD) [8]. 
The IRSAD scores reflect the overall level of advantage and 
disadvantage measured at the area-level, and captures a wide 
range of socioeconomic attributes including education, oc-
cupation, income, unemployment and household structure. 
For analyses, participants were categorised into quintiles of 
SES based on their IRSAD scores using cut-points for the 
Barwon Statistical Division as determined by the ABS. 
Quintile 1 denotes the most disadvantaged area, and quintile 
5 the most advantaged.  
Statistics 
 Prevalence data were standardised by age and gender to 
Australian population profiles (ABS Catalogue No. 2001.0). 
Associations between H1N1 seropositivity (outcome) and 
gender, occupation, employment status, household living 
arrangements, pregnancy status, medication use, smoking, 
alcohol consumption, chronic respiratory disease, chronic 
heart disease, diabetes and SES (exposures) were determined 
using multivariable regression analysis. Models were tested 
for confounders and effect modifiers. Statistical analyses 
were performed using Minitab (version 15; Minitab, State 
College, PA, USA). 
RESULTS 
Prevalence 
 Of 1184 individuals (569 men and 615 women), 129 (58 
men and 71 women) were seropositive. Age- and gender-
adjusted prevalence was 8.3% for age 20-29 years, 13.5% for 
30-39 years, 10.4% for 40-49 years, 6.5% for 50-59 years, 
9.7% for 60-69 years, 10.3% for 70-79 years and 18.8% for 
80+ (Fig. 1). Standardised prevalence for age 20+ was 
10.3%. (95%CI 9.6-11.0). 
 Subject characteristics are shown, overall, and according 
to H1N1 infection status in Table 1. A greater proportion of 
seropositive individuals were smokers, fewer than expected 
seropositive individuals were self-employed and more than 
expected were not employed and seropositive individuals 
tended to be over-represented in the lowest SES quintile and 
under-represented in the highest SES quintile. No differences 
in H1N1 seropositive status were detected between those 
with chronic respiratory disease, pregnancy, obesity or dia-
betes, while those with chronic heart disease tended to be 
over-represented in the seropositive group. 
Risk Factors for H1N1 Seropositivity 
 Smokers were more likely to be seropositive (OR=1.86, 
95%CI 1.09-3.15, p=0.02). Compared to those who were 
employed fulltime, there was a trend for those self-employed 
to be less likely to be seropositive (OR=0.31, 95%CI 0.07-
1.35, p=0.1). 
 No associations were detected between H1N1 infection 
and gender (OR=0.82 95%CI 0.57-1.19, p=0.3), being a 
healthcare worker (OR=1.43, 95%CI 0.62-3.29, p=0.4), hav-
ing chronic respiratory disease (OR=0.92, 95%CI 0.50-1.69, 
p=0.8) or chronic heart disease (OR=1.50, 95%CI 0.70-3.23, 
p=0.3), being obese (OR=0.98, 95%CI 0.65-1.46, p=0.9) or 
diabetic (OR=0.73, 95%CI 0.36-1.50, p=0.4); there was a 
trend for increased risk among childcare-workers/teachers 
(OR=1.93, 95%CI 0.87-4.30, p=0.1) and those living with 
children (OR=1.57, 95%CI 0.85-2.90, p=0.2). Individuals in 
the lowest SES quintile were 2.5-fold more likely to be sero-
positive than those who were least disadvantaged (OR=2.52, 
95%CI 1.24-5.13, p=0.01). This association was not ex-
plained by smoking habits, employment, living with children 
or the number of people living in the household. 
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Fig. (1). The prevalence of seropositivity by age. The lower portion of bars represents those who reported influenza-like symp-
toms. The error bars represent the standard error. 
Symptoms 
 Among 129 seropositive individuals, symptoms were 
reported by 24.0% (n=31): for 10.1% (n=13) symptoms were 
mild, 14.0% (n=18) moderate (6 time off work, 16 doctor 
visit) and none was severe (no hospitalisations). Two had 
diagnostic tests performed for H1N1 infection; none was 
prescribed treatment. Raw data showed that for age <60 
years, 39.6% reported symptoms whereas the proportion was 
13.2% for age 60+. The age- and gender-adjusted propor-
tions of seropositive individuals who reported influenza-type 
symptoms are shown in Fig. (1).  
 Upper respiratory tract symptoms were reported in 26 
symptomatic individuals (17 sore throat, 22 cough, 16 runny 
nose, 13 shortness of breath, 13 sinus congestion); two with 
gastrointestinal symptoms (1 diarrhoea, 2 vomiting); 25 with 
constitutional symptoms (18 headache, 19 fatigue, 12 chills, 
16 body ache) and 18 with other symptoms (4 chest pain, 12 
stiffness, 6 ear ache, 3 conjunctivitis). 
DISCUSSION 
 Historically, a pandemic strain of influenza appears peri-
odically every second generation, at times with devastating 
virulence. In this population-based study among adults dur-
ing the first wave of pandemic H1N1 infection in Australia, 
we found an overall prevalence of 10.3%. The proportion of 
adults who were seropositive was relatively low in view of 
the susceptibility of the population. This was highest in 
young adults with the exception of the over 80 year cohort, 
possibly related to previous immunity from circulating 
H1N1 strains before 1957. This is also supported by the very 
low symptom rate for the older age group who were found to 
be seropositive. 
 Our study found a similar age pattern as that of a median 
of 21-22 years in symptomatic laboratory confirmed cases of 
pandemic influenza from sentinel surveillance sites in Victo-
ria and Western Australia [9]. The low virulence of this pan-
demic strain was comparable to seasonal influenza with sig-
nificant subclinical infection found. An opportunistic sero-
logical survey among children in Western Australia follow-
ing the 2009 pandemic reported that 25% of preschool and 
40% of school age children had evidence of recent infection 
[10]. Most were asymptomatic although this was not care-
fully assessed given the limits in methodology in this study. 
These results and our findings provide some support for the 
early public health response of pre-emptive school closures 
to delay community transmission rather than awaiting the 
onset of symptomatic infection to drive decision making 
pending the availability of an effective vaccine. 
 Overall there was substantial subclinical infection and we 
found low rates of clinical disease with mild and moderate 
symptoms requiring time off work or seeking medical atten-
tion and there were no hospitalisations. 
 We found that history of contact with children increased 
the likelihood of infection, and a recent transmission study 
during the seasonal influenza season found a five-fold in-
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crease in secondary household cases following confirmed 
influenza in index child cases [11]. Among health workers 
we did not find an increased infection risk compared to 
background. Additional precautions and use of personal pro-
tective equipment were widely used across health services 
during the H1N1 pandemic and may have contributed to this 
risk reduction. We did not observe an increased risk associ-
ated with obesity; limited numbers restricted our ability to 
further explore the relationship with pregnancy. 
 We observed a clear inverse association with SES for 
infection and this relationship was not explained by smoking 
Table 1. Subject Characteristics for the Whole Group and According to Seropositivity. Data are Presented as Mean (±SD) or n 
(%). 
Seropositive  
All n=1184 
Yes n = 129 No n = 1055 p 
Male 569 (48.1%) 58 (45.0%) 511 (48.4%) 0.46 
Age (yr) 60.5 (16.8) 62.9 (19.6) 60.3 (16.4) 0.16 
BMI (kg/m2) 28.1 (5.3) 28.2 (5.6) 28.1 (5.2) 0.87 
Obese (BMI>30.0 kg/m2) 353 (29.8%) 38 (29.5%) 315 (29.9%) 0.93 
Current smoker 123 (10.4%)  20 (15.5%) 103 (9.8%) 0.04 
Healthcare worker 53 (4.5%) 7 (5.4%) 46 (4.4%) 0.59 
Childcare worker/teacher 48 (4.1%) 8 (6.2%) 40 (3.8%) 0.19 
Employment status    0.05 
 Full-time 284 (24.0%) 27 (20.9%) 257 (24.4%)  
 Part-time 139 (11.7%) 10 (7.8%) 129 (12.2%)  
 Casual 64 (5.4%) 7 (5.4%) 57 (5.4%)  
 Self-employed 63 (5.3%) 2 (1.6%) 61 (5.8%)  
 Not employed 634 (53.6%) 83 (64.3%) 551 (52.2%)  
Highest level of education    0.18 
 Primary 75 (6.3%) 11 (8.5%) 64 (6.1%)  
 Some secondary 393 (33.2%) 52 (40.3%) 341 (32.3%)  
 Completed secondary 276 (23.3%) 22 (17.1%) 254 (24.1%)  
 Post-secondary 152 (12.8%) 14 (10.9%) 138 (13.1%)  
 Tertiary 288 (24.3%) 30 (23.3%) 258 (24.5%)  
Lives alone 196 (16.6%) 27 (20.9%) 169 (16.0%) 0.16 
Lives with children aged <12 yr 161 (13.6%) 19 (14.7%) 142 (13.5%) 0.69 
Socioeconomic status    0.11 
 Quintile 1 (low) 234 (19.8%) 35 (27.1%) 199 (18.9%)  
 Quintile 2 272 (23.0%) 30 (23.3%) 242 (22.9%)  
 Quintile 3 280 (23.7%) 27 (20.9%) 253 (24.0%)  
 Quintile 4 231 (19.5%) 26 (20.2%) 205 (19.4%)  
 Quintile 5 167 (14.1%) 11 (8.5%) 156 (14.8%)  
Chronic respiratory disease 129 (10.9%) 13 (10.1%) 116 (11.0%) 0.75 
Pregnancy 13 (1.1%) 1 (0.8%) 12 (1.1%) 1 
Chronic heart disease 53 (4.5%) 9 (7.0%) 44 (4.2%) 0.15 
Diabetes 99 (8.4%) 9 (7.0%) 90 (8.5%) 0.55 
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habits, employment, living with children or the number of 
people living in the household. Compliance with precaution-
ary recommendations to control the spread of H1N1 has 
been associated with greater educational attainment in stud-
ies of adults from the USA [12] and Singapore [13]. Percep-
tion of a health threat, and compliance with preventive 
measures, are more likely to occur for those with greater 
health literacy [14] - a construct referring to the capacity of 
an individual to obtain and understand health information 
and employ specific health-related behaviours that are effec-
tive in reducing the risk of disease, and one which has been 
associated with higher education and income. In contrast, 
those with lower health literacy are, in theory, more likely to 
engage in risk-taking behaviour, more likely to be influenced 
by peers, and less likely to comply with recommended pre-
ventive measures.  
 It is a given that greater transmission intensity correlates 
with spatial concentrations of individuals [15]. Those of 
lower SES are more likely to experience spatial concentra-
tions of populations, for instance on public transport such as 
buses and trains. Whilst we were unable to account for spa-
tial concentrations and/or public transport use, a study of 
adult males and females from Singapore reported a higher 
seroconversion rate associated with use of local public trans-
port [16]. Whilst a Canadian study found no association be-
tween public transport and H1N1 [17], this discrepancy may 
be explained by the study methodology whereby participants 
were primarily recruited from urban areas, thus potentially 
limiting the range of socioeconomic groups included for 
analysis. However, that same Canadian study reported that 
large social gatherings were associated with an increased 
likelihood of seroconversion [17]. Furthermore, individuals 
of greater social disadvantage are more likely to have smaller 
homes [18] and, whilst living with children or the number of 
people living in the household did not explain our findings, 
we were unable to examine population density relative to the 
size of the home. Although the precise implications of com-
munity-specific factors on seropositivity remain unknown, 
targeted educational and behavioural interventions to im-
prove respiratory, and hand, hygiene practices to reduce dis-
ease transmission would be well directed toward those of 
greater social disadvantage using readily accessible avenues 
such as television. 
 The strength of this study is that it is population-based. 
Furthermore, serology was performed independently by 
laboratory technicians who were blinded to questionnaire 
data and clinical measures. However, we acknowledge sev-
eral limitations. The study involved adults only. The accu-
racy of self-reported data concerning symptoms, employ-
ment and lifestyle practices may have been subject to recall 
bias. It also remains unknown how many influenza infec-
tions lead to seropositivity at convalescence. Unless this 
fraction is high, seropositivity may be a poor measure of 
cumulative incidence of infection. Given that subclinical 
infections are difficult to confirm virologically, while sero-
logic response is correlated with disease severity, this frac-
tion is likely to remain elusive.  
CONCLUSION 
 This study provides some important evidence to inform 
key public health interventions, at the individual-behaviour 
level and at the level of population-wide health promotion 
messages, in an influenza pandemic response. These include 
protection of vulnerable populations such as the elderly and 
socially disadvantaged groups. The reasons predisposing 
these groups to H1N1 infection remain to be understood. 
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